Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease

Priyanka Khandelwal1, Vijaya Murugan1, Smriti Hari2

  • 1Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Insights

Children with chronic kidney disease (CKD) have higher rates of dyslipidemia and atherosclerosis, indicated by increased carotid artery intima-media thickness (cIMT). Elevated LDL cholesterol is linked to higher cIMT, suggesting increased cardiovascular risk in pediatric CKD.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Research
  • Clinical Biochemistry

Background:

  • Chronic kidney disease (CKD) in children is associated with accelerated atherosclerosis.
  • Carotid artery intima-media thickness (cIMT) and brachial artery flow-mediated dilation (FMD) are key markers of atherosclerosis.
  • Limited data exists on dyslipidemia's impact on these markers in pre-dialysis pediatric CKD.

Purpose of the Study:

  • To investigate the association between dyslipidemia and atherosclerosis markers (cIMT, FMD) in pre-dialysis pediatric CKD patients.
  • To identify predictors of dyslipidemia and elevated cIMT in this population.

Main Methods:

  • Cross-sectional analysis of 80 pre-dialysis pediatric CKD patients and 42 controls.
  • Evaluation of lipid profiles, cIMT, and brachial artery FMD.
  • Statistical analysis using Student's t test, linear regression, and logistic regression.

Main Results:

  • Pediatric CKD patients exhibited significantly higher triglyceride, total cholesterol, and LDL cholesterol levels compared to controls.
  • Dyslipidemia was prevalent in 73.8% of patients.
  • Patients showed significantly higher cIMT and reduced FMD compared to controls.
  • Hypertension and male gender were associated with dyslipidemia; elevated LDL cholesterol predicted increased cIMT.

Conclusions:

  • Dyslipidemia and elevated cIMT are common in pre-dialysis pediatric CKD, signaling increased cardiovascular risk.
  • The findings highlight a strong link between dyslipidemia, particularly elevated LDL cholesterol, and atherosclerosis in early-stage pediatric kidney disease.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
925
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
585
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K